Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide

Although tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) have been evaluated in various clinical trials, limited safety and efficacy data exist in real-world settings. The goal of this retrospective analysis is to assess changes in virological suppression, immunological status, r...

Full description

Bibliographic Details
Main Authors: Sarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, Eric Wenzler, Rodrigo M Burgos, Renata O Smith, Melissa E Badowski
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-07-01
Series:Drugs in Context
Subjects:
antiretroviral
hiv
reverse transcriptase inhibitor
switch
tenofovir
Online Access:https://drugsincontext.com/real-world-impact-of-switching-from-tenofovir-disoproxil-fumarate-to-tenofovir-alafenamide

Internet

https://drugsincontext.com/real-world-impact-of-switching-from-tenofovir-disoproxil-fumarate-to-tenofovir-alafenamide

Similar Items